Literature DB >> 3486745

Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis.

C C Chan, J J Hooks, R B Nussenblatt, B Detrick.   

Abstract

Recently, human retinal pigment epithelial (RPE) cells have been demonstrated to express class II, HLA-DR, antigens both in vivo and in vitro. HLA-DR antigens were detected on RPE cells from patients with uveitis and retinitis pigmentosa. In addition, in vitro studies revealed that not only does this cell express HLA-DR antigen but also that this antigen can be modulated by the lymphokine, interferon (IFN)-gamma. In this study we evaluated the development of the murine class II, Ia, antigens on RPE cells in experimental autoimmune uveoretinitis (EAU). Ia antigen was evaluated with the avidin-biotin-peroxidase technique. Ia antigen was not detected on RPE cells from normal rats. However, Ia antigen was detected on the surface of RPE cells from EAU rats four days prior to the development of clinical and histopathological EAU. Moreover, the expression of Ia antigen on RPE cells from EAU rats continued to persist until one and one-half months after immunization. This study demonstrates that during the course of EAU the RPE cell is activated to express Ia antigens. This antigen expression may be important in the initiation and/or perpetuation of immune reactivity in the eye.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486745     DOI: 10.3109/02713688609020059

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  10 in total

1.  Interferon-gamma (IFN-gamma) production in vivo in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

Review 2.  Immunopathology of uveitis.

Authors:  C C Chan; Q Li
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

3.  The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.

Authors:  S E Coupland; L Krause; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

4.  Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia.

Authors:  A D Dick; A L Ford; J V Forrester; J D Sedgwick
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

5.  Immunocytochemical study of retinal diode laser photocoagulation in the rat.

Authors:  P R Richardson; M E Boulton; J Duvall-Young; D McLeod
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

6.  MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.

Authors:  Deborah A Lipski; Rémi Dewispelaere; Vincent Foucart; Laure E Caspers; Matthieu Defrance; Catherine Bruyns; François Willermain
Journal:  J Neuroinflammation       Date:  2017-07-18       Impact factor: 8.322

7.  EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A.

Authors:  J Liversidge; A W Thomson; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

8.  Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.

Authors:  J M Liversidge; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A.

Authors:  J Liversidge; H F Sewell; A W Thomson; J V Forrester
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

Review 10.  Experimental autoimmune uveoretinitis (EAU) versus experimental allergic encephalomyelitis (EAE): a comparison of T cell-mediated mechanisms.

Authors:  V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.